ACC.26 前瞻 | 超百项研究成果闪耀国际舞台，尽显中国科研硬核实力
发布时间：2026-02-05 20:10:21 浏览量：1
当地时间3月28日-30日，第75届美国心脏病学会科学年会（ACC.26）将于美国新奥尔良盛大启幕。作为全球心血管领域顶级学术盛会，本届年会汇聚全球心血管领域前沿成果，其中中国学者超百项研究成功入选，覆盖结构性心脏病、高血压、冠状动脉疾病、心力衰竭、心律失常、瓣膜病等多个领域，全方位展现中国心血管领域的科研创新能力与临床实践水平。
本文基于官网披露信息梳理了中国学者入选报告（截至2月4日），如有遗漏或错误，欢迎留言补充指正。下面跟随小编一起，共览中国心血管科研的国际风采。
（以下所有时间为当地时间）
3月28日
1004. Basic and Translational Ischemic Heart Disease
9:30AM Moderated Poster Contributions
1004-05 LEUKOCYTE CELL-DERIVED CHEMOTAXIN 2 AS A REGULATOR OF ENDOTHELIAL ANGIOGENESIS AND CARDIAC REMODELING AFTER MYOCARDIAL INFARCTION
1004-05
白细胞衍生趋化因子2作为心肌梗死后内皮血管生成和心脏重塑的调节因子
邹普 中南大学湘雅二医院
1004-07 CRISPR BASED RESTORATION OF MEX3A EXPRESSION RESCUES IMPAIRED AUTOPHAGY IN DIABETIC ATHEROSCLEROSIS MODELS
1004-07
基于CRISPR恢复MEX3A表达可挽救糖尿病动脉粥样硬化模型中受损的自噬功能
Hengwei Xu 陕西省人民医院
1004-11 NLRP3 INFLAMMASOME INHIBITION RESCUES DEFECTIVE MITOPHAGY AND STABILIZES DIABETIC ATHEROSCLEROTIC PLAQUES
1004-11
NLRP3炎症小体抑制可挽救线粒体自噬缺陷并稳定糖尿病动脉粥样硬化斑块
张勇 陕西省人民医院
1005. Advances in Hypertension Management
9:30AM Moderated Poster Contributions
1005-11 SUSTAINED REDUCTIONS IN ANGIOTENSINOGEN AND BLOOD PRESSURE WITH AN RNA INTERFERENCE THERAPEUTIC: INTERIM RESULTS FROM A FIRST-IN-HUMAN PHASE 1 STUDY OF GW906 IN CHINA
1005-11
RNA干扰来疗法可持续降低血管紧张素原和血压：GW906中国首次人体1期研究的中期结果
李海燕 北京大学第三医院
1007. Advancing Valve Interventions: Integrating Emerging Evidence to Refine Clinical Decision Making
9:30AM Moderated Poster Contributions
1007-05 COMPARATIVE OUTCOMES OF TRANSCATHETER AORTIC VALVE REPLACEMENT USING A DEDICATED DEVICE VERSUS SURGICAL REPLACEMENT IN PURE NATIVE AORTIC REGURGITATION: A PROPENSITY SCORE-MATCHED ANALYSIS
1007-05
使用专用器械经导管主动脉瓣置换术（TAVR）与外科手术治疗在单纯性原发主动脉瓣反流中的比较结局：一项倾向评分匹配分析
Yuqiang Wang 四川大学华西医院
1304. Ischemic Heart Diseases 01
9:30AM Poster Contributions
1304-070 TOTAL AND COMPOSITIONAL PLAQUE BURDEN ON CORONARY CTA INDEPENDENTLY PREDICT SHORT-TERM RISK OF ACUTE MYOCARDIAL INFARCTION
1304-070
冠状动脉CTA总斑块负荷及成分斑块负荷可独立预测急性心肌梗死的短期风险
Jingyao Yang 首都医科大学附属北京安贞医院
1304-078 RELATIONSHIP BETWEEN CYCLIC GMP-AMP (CGAMP) AND SEVERE CORONARY STENOSIS: INSIGHT FROM MACHINE LEARNING AND SHAPLEY ADDITIVE EXPLANATIONS ANALYSIS
1304-078
环状GMP-AMP（cGAMP）与重度冠状动脉狭窄之间的关系：来自机器学习和Shapley加性解释分析的见解
Quan Zhang 中南大学湘雅二医院
1304-080 CORONARY CT ANGIOGRAPHY-DERIVED PREDICTORS OF PROGRESSION FROM NONOBSTRUCTIVE LESIONS TO CULPRIT LESIONS IN ACUTE MYOCARDIAL INFARCTION
1304-080
基于冠状动脉CT血管造影的从非阻塞性病变进展为急性心肌梗死罪犯病变的预测因子
Jingyao Yang 首都医科大学附属北京安贞医院
1306. Multimodal Imaging 01
9:30AM Poster Contributions
1306-091 A NOVEL CCTA-BASED VASCULAR RISK SCORING SYSTEM PREDICTS CARDIOVASCULAR EVENTS IN NON-OBSTRUCTIVE CORONARY ARTERY DISEASE: RESULTS FROM THE CHINA CT-FFR STUDY-2
1306-091
一种新型基于CCTA的血管风险评分系统预测非阻塞性冠状动脉疾病患者的心血管事件：来自中国CT-FFR研究-2的结果
Haixin Liu 中国人民解放军东部战区总医院
1309. Valvular Diseases 01
9:30AM Poster Contributions
1309-135 SYSTEMIC INFLAMMATION MODERATE THE ASSOCIATION BETWEEN URINARY POLYCYCLIC AROMATIC HYDROCARBON METABOLITES AND HYPERTENSIVE ADULTS
1309-135
系统性炎症调节尿液中多环芳烃代谢物与高血压成人之间的关联
祝领 陕西省人民医院
1017. From Protocols to Partnerships: Operational Strategies Transforming Cardiovascular Care
11:00AM Moderated Poster Contributions
1017-11
护士主导的增强康复路径在心脏外科中的真实世界效果：与较少的并发症和较低的资源消耗相关
Jinyao Su 陕西省人民医院
1019. Cellular Biology of Atherosclerotic Plaque
11:00AM Moderated Poster Contributions
1019-07 MEX3A DEFICIENCY AMPLIFIES FERROPTOSIS AND ACCELERATES NECROTIC CORE EXPANSION IN DIABETIC ATHEROSCLEROSIS
1019-07
MEX3A缺乏加剧铁死亡并加速糖尿病动脉粥样硬化中坏死核心扩张
刘仲伟 陕西省人民医院
1019-09 OXIDIZED LDL TRIGGERS PYROPTOSIS IN VASCULAR SMOOTH MUSCLE CELLS AND SALIDROSIDE TREATMENT MITIGATES THIS PATHWAY TO IMPROVE PLAQUE STABILITY
1019-09
氧化低密度脂蛋白触发血管平滑肌细胞发生细胞焦亡，红景天苷治疗可缓解该通路以改善斑块稳定性
Hengwei Xu 陕西省人民医院
1020. Aldosterone Synthase Inhibitors: What's New?
11:00AM Moderated Poster Contributions
1020-05 VB19055: A NOVEL ALDOSTERONE SYNTHASE INHIBITOR WITH IMPROVED SELECTIVITY AND EFFICACY
1020-05
VB19055：一种具有更高选择性和疗效的新型醛固酮合酶抑制剂
DOUGLAS FANG 浙江
1021. A Jambalaya of Knowledge: Pulmonary Vascular Disease
11:00AM Moderated Poster Contributions
1021-07 DECIPHERING THE COMMON MECHANISMS OF PULMONARY HYPERTENSION SUBTYPES USING MULTI-OMICS AND MACHINE LEARNING
1021-07
利用多组学和机器学习解析肺动脉高压亚型的共同机制
郭媛 中南大学湘雅医学院附属株洲医院
1030. ACC Complex Clinical Cases: Heart Failure and Cardiomyopathies (Session 2)
11:00AM Moderated Poster Contributions
1030-07 FABRY CARDIOMYOPATHY PRESENTING AS HYPERTROPHIC PHENOTYPE WITH LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION: A CASE SERIES
1030-07
表现为左室流出道梗阻的肥厚型表型的法布雷病：病例系列
黄毕 重庆医科大学附属第一医院
1325. Featured Fields 02
11:00AM Poster Contributions
1325-029 THE ASSOCIATION BETWEEN BIOLOGICAL AGING AND CORONARY MICROVASCULAR DYSFUNCTION
1325-029
生物学衰老与冠状动脉微血管功能障碍的关联
陆浩 复旦大学附属中山医院
1326. Cardiovascular Disease Prevention 02
11:00AM Poster Contributions
1326-038 THE ARTIFICIAL SWEETENER SUCRALOSE MAY EXACERBATE ATHEROSCLEROSIS VIA ALTERATIONS IN GUT MICROBIOTA AND METABOLITE PROFILES
1326-038
人工甜味剂三氯蔗糖可能通过改变肠道微生物群和代谢物谱加剧动脉粥样硬化
Yu Feng 中南大学湘雅二医院
1326-044 B LYMPHOCYTES CONTRIBUTE ANGIOTENSIN II INDUCED CARDIAC HYPERTROPHY
1326-044
B淋巴细胞在血管紧张素II诱导的心脏肥大中的作用
伍航利 陕西省人民医院
1326-056 PK/PD CHARACTERISTICS OF BECONDOGREL IN HEALTHY SUBJECTS WITH DIFFERENT CYP2C19 METABOLIC GENOTYPES
1326-056
健康受试者中不同CYP2C19代谢基因型下Becondogrel的药代动力学/药效学特征
Ming Chen 成都
1331. Cardiac Arrhythmias 02
11:00AM Poster Contributions
1331-103 STEREOTACTIC BODY RADIOTHERAPY MODULATES ATRIAL ELECTROPHYSIOLOGY AND REDUCES ATRIAL FIBRILLATION SUSCEPTIBILITY: MECHANISTIC EVIDENCE FROM MURINE MODELS
1331-103
立体定向体部放疗调节心房电生理并降低心房颤动易感性：来自小鼠模型的机制证据
Zihan Jiang 心血管疾病国家重点实验室
1332. Coronary, Peripheral and Structural Interventions 02
11:00AM Poster Contributions
1332-114 ASSOCIATION BETWEEN NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL TO HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO (NHHR) AT ONE YEAR AFTER CORONARY ARTERY BYPASS GRAFTING AND LONG-TERM OUTCOMES IN PATIENTS WITH MULTIPLE VESSEL DISEASE: A RETROSPECTIVE COHORT STUDY
1332-114 冠状动脉旁路移植术（CABG）后1年非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值（NHHR）与多支血管病变患者长期预后的相关性：一项回顾性队列研究
唐亮 中南大学湘雅二医院
1332-115 PROGNOSTIC VALUE OF THE ATHEROGENIC INDEX OF PLASMA IN PATIENTS WITH MULTIVESSEL CORONARY DISEASE UNDERGOING CABG: A RETROSPECTIVE COHORT STUDY
1332-115
血浆致动脉粥样硬化指数在接受CABG的多支冠状动脉病变患者的预后价值：一项回顾性队列研究
唐亮 中南大学湘雅二医院
1332-126 ADOPTION OF INTRAVASCULAR IMAGING-GUIDED PERCUTANEOUS CORONARY INTERVENTION IN THE UNITED STATES (2012-2022): TEMPORAL TRENDS, DISPARITIES, AND MORTALITY ASSOCIATION
1332-126
美国血管内影像引导下经皮冠状动脉介入治疗（PCI）的采用情况（2012-2022年）：时间趋势、差异与死亡率的关联
佟倩 吉林大学第一医院
1347. Heart Failure and Cardiomyopathies 02
11:00AM Poster Contributions
1347-218 NLRP3 INFLAMMASOME BLOCKADE IMPROVES VASCULAR-VENTRICULAR COUPLING AND DIASTOLIC FUNCTION AFTER TRANSVERSE AORTIC CONSTRICTION
1347-218
阻断NLRP3炎症小体改善主动脉弓缩窄（TAC）术后血管-心室耦合及舒张功能
潘硕 陕西省人民医院
1347-219 RESTORING THE ENDOTHELIAL GLYCOCALYX REVERSES NITRIC-OXIDE MECHANOTRANSDUCTION DEFECTS AND LIMITS PRESSURE-OVERLOAD REMODELING IN TAC
1347-219
恢复内皮糖萼可逆转一氧化氮机械转导缺陷并限制TAC模型中的压力超负荷重塑
潘硕 陕西省人民医院
1347-233 DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR INTERMEDIATE- AND LONG-TERM SURVIVALIN PATIENTS WITH PERICARDITIS
1347-233
心包炎患者中长期生存预测模型的开发与验证
lingyu Mi 中国医学科学院阜外医院
1347-239 C-REACTIVE PROTEIN TO ALBUMIN RATIO AND LONG-TERM MORTALITY IN PERICARDITIS
1347-239
C反应蛋白与白蛋白比值与心包炎患者的长期死亡率
lingyu Mi 中国医学科学院阜外医院
902. Highlighted Original Research: Valvular Diseases
11:00AM Oral Contributions
902-05 EARLY VERSUS CLASS I-TRIGGERED SURGERY IN SEVERE AORTIC REGURGITATION: IMPACT ON LONG-TERM SURVIVAL AND LEFT VENTRICULAR REMODELING
902-05
早期手术与I类指征触发手术在重度主动脉瓣反流中的比较：对长期生存率和左心室重构的影响
Yuqiang Wang 四川大学华西医院
1034. Cardiac Imaging Research: From Data to Decision
12:30PM Moderated Poster Contributions
1034-09 AL¹⁸F-NOTA-PEG₂-ECL1I: A NOVEL C-C CHEMOKINE RECEPTOR TYPE 2 RADIOTRACER FOR CARDIAC INFLAMMATION IMAGING
1034-09
AL¹⁸F-NOTA-PEG₂-ECL1I：一种用于心脏炎症成像的新型C-C趋化因子受体2型放射性示踪剂
Shuyang Song 中国医学科学院阜外医院
1035. Innovation in Coronary Revascularization
12:30PM Moderated Poster Contributions
1035-03 LONG-TERM PROGNOSTIC VALUE OF COMBINED IVUS AND ANGIOGRAPHY-DERIVED IMR ASSESSMENT IN INTERMEDIATE CORONARY STENOSIS: INSIGHTS FROM THE FLAVOUR STUDY
1035-03
联合血管内超声（IVUS）与血管造影衍生的微循环阻力指数（IMR）评估在中度冠状动脉狭窄中的长期预后价值：来自FLAVOUR研究的见解
蒋峻 浙江大学医学院附属第二医院
1035-09 ENHANCED EXTERNAL COUNTERPULSATION IMPROVES CT-DERIVED FRACTIONAL FLOW RESERVE IN PATIENTS WITH INTERMEDIATE-RISK CHRONIC CORONARY SYNDROME: A PROSPECTIVE, MULTICENTER RANDOMIZED CONTROLLED TRIAL
1035-09
增强型体外反搏改善中危慢性冠状动脉综合征患者的CT衍生血流储备分数（FFR）：一项前瞻性、多中心随机对照试验
伍贵富 中山大学附属第八医院
1037. Evolving Tools For CVD Prediction
12:30PM Moderated Poster Contributions
1037-05 COMPARATIVE PROGNOSTIC VALUE OF NINE CARDIORENAL BIOMARKERS FOR MORTALITY AMONG ADULTS WITH PREDIABETES AND DIABETES
1037-05
九种心肾生物标志物在糖尿病前期和糖尿病成人患者中对死亡率的比较预后价值
祝领 陕西省人民医院
1037-09 PROGNOSTIC VALUE OF FIBROSIS-4 INDEX FOR ALL-CAUSE AND CARDIAC MORTALITY IN PATIENTS WITH CORONARY HEART DISEASE COMBINED WITH DIABETES OR PREDIABETES:FINDINGS FROM TWO LARGE-SCALE PROSPECTIVE COHORT STUDIES
1037-09
FIBROSIS-4指数对冠心病合并糖尿病或糖尿病前期患者全因死亡及心脏性死亡率的预后价值：来自两项大规模前瞻性队列研究的发现
Bowen Li 中国医学科学院阜外医院
1042. Unpacking HFpEF With Proteomics, Metabolism and Microvascular Mechanisms
12:30PM Moderated Poster Contributions
1042-07 OXIDATIVELY DAMAGED MITOCHONDRIAL CARGO IN ADIPOCYTE EXTRACELLULAR VESICLES LINKS DIABETES TO HEART FAILURE WITH PRESERVED EJECTION FRACTION
1042-07
脂肪细胞外囊泡中氧化损伤的线粒体货物将糖尿病与射血分数保留的心力衰竭（HFpEF）联系起来
HAIBIN JI 南京医科大学第一附属医院
1042-09 TRANSCRIPTOME COMBINED WITH SINGLE-CELL ANALYSIS TO IDENTIFY GLUCOSE METABOLISM-RELATED KEY GENES IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION BY EMPAGLIFLOZIN
1042-09
转录组结合单细胞分析鉴定恩格列净治疗HFpEF中与葡萄糖代谢相关的关键基因
Fengchao Wu 陕西省人民医院
1349. Featured Fields 03
12:30PM Poster Contributions
1349-021 ASSOCIATION BETWEEN EARLY POSTOPERATIVE ADMINISTRATION OF PROTON PUMP INHIBITORS OR HISTAMINE 2 RECEPTOR ANTAGONIST AND POSTOPERATIVE DELIRIUM IN CARDIAC SURGERY PATIENTS
1349-021
心脏手术患者术后早期使用质子泵抑制剂或组胺H2受体拮抗剂与术后谵妄之间的关联
RAN AN 中国医学科学院阜外医院
1349-025 DEVELOPMENT AND VALIDATION OF AN INTERPRETABLE RISK PREDICTION MODEL FOR VA-ECMO-RELATED ACUTE KIDNEY INJURY IN CHILDREN: A MULTICENTER RETROSPECTIVE COHORT STUDY IN CHINA
1349-025
可解释儿童VA-ECMO相关急性肾损伤风险预测模型的开发与验证：一项中国多中心回顾性队列研究
Ran Zhang 中国人民解放军总医院
1349-032 PROGNOSTIC VALUE OF GLYCEMIC VARIABILITY FOR LONG-TERM MORTALITY IN CRITICALLY ILL PATIENTS WITH DIABETES AND CARDIOVASCULAR DISEASE
1349-032
血糖变异性对糖尿病合并心血管疾病危重患者长期死亡率的预后价值
Yanfeng Yi 中南大学湘雅二医院
1350. Cardiovascular Disease Prevention 03
12:30PM Poster Contributions
1350-046 DEVELOPMENT OF AN ONLINE RISK CALCULATOR BASED ON THE REMNANT CHOLESTEROL INFLAMMATORY INDEX TO PREDICT MORTALITY IN U.S. ADULTS: A POPULATION-BASED STUDY
1350-046
基于残余胆固醇炎症指数的在线风险计算器开发用于预测美国成年人死亡率：一项基于人群的研究
陈艳 大连医科大学附属第二医院
1350 ASSOCIATION BETWEEN DIET PATTERNS AND PROGRESSION OF CORONARY ARTERY CALCIFICATION: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS
1350
饮食模式与冠状动脉钙化进展的关联：多民族动脉粥样硬化研究
M. Momin 北京
1350-050 DISEASE BURDEN AND EPIDEMIOLOGY OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND SYSTEMIC INFLAMMATION IN EASTERN CHINA: A RETROSPECTIVE ELECTRONIC HEALTH RECORDS STUDY
1350-050
中国东部动脉粥样硬化性心血管疾病（ASCVD）、慢性肾脏病（CKD）和系统性炎症的疾病负担与流行病学：一项回顾性电子健康记录研究
Hongye Ren 东南大学附属中大医院
1350-059 ALCOHOL USE AT MID-LIFE AND ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY
1350-059
中年酒精使用与全因及特定原因死亡率
ziyue li 中南大学湘雅二医院
1357. Valvular Diseases 03
12:30PM Poster Contributions
1357-135 IMPACT OF THE WHOLE-LIFE CYCLE MANAGEMENT SYSTEM ON CLINICAL OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
1357-135
全生命周期管理系统对TAVR术后临床结局的影响
Zechao Ran 四川大学华西医院
1358. Vascular Diseases 03
12:30PM Poster Contributions
1358-136 ACUTE TYPE A AORTIC DISSECTION: DOES EXTENSIVE REPAIR OUTPERFORM PROXIMAL REPAIR?
1358-136
急性A型主动脉夹层：广泛修复是否优于近端修复？
Sichong Qian 首都医科大学附属北京安贞医院
1372. CV Team 04
2:00PM Poster Contributions
1372-004 ELECTROCARDIOGRAPHIC AND RESPIRATORY MONITORING DURING SLEEP IN HYPERTENSIVE PATIENTS WITH PULMONARY HYPERTENSION
1372-004
高血压合并肺动脉高压患者睡眠期间的心电图与呼吸监测
Jin Liu 广东省人民医院
1373. Featured Fields 04
2:00PM Poster Contributions
1373-011 SIMULATION- AND ARTIFICIAL INTELLIGENCE-ASSISTED TRAINING FOR CORONARY ANGIOGRAPHY AND PCI: A SYSTEMATIC REVIEW AND META-ANALYSIS
1373-011
基于模拟和人工智能辅助的冠状动脉造影和经皮冠状动脉介入治疗训练：一项系统综述与荟萃分析
Yang Qianyi 安徽大学
1373-018 IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDIAL FIBROSIS IS DRIVEN BY MACROPHAGE DERIVED EXOSOMES CARRYING PRO-FIBROTIC MICRORNAS
1373-018
免疫检查点抑制剂相关性心肌纤维化由携带促纤维化微小RNA的巨噬细胞来源外泌体驱动
张勇 陕西省人民医院
1374. Cardiovascular Disease Prevention 04
2:00PM Poster Contributions
1374-033 GUT MICROBIAL SIGNATURES OF HYPERTENSION ASSOCIATED WITH DIETARY AND SLEEP PHENOTYPES
1374-033
与饮食和睡眠表型相关的高血压肠道微生物特征
Xiaoyi Li 北京大学
1374-040 SERUM URIC ACID, ARTERIAL STIFFNESS, AND MORTALITY: EVIDENCE FROM NHANES AND UK BIOBANK
1374-040
血清尿酸、动脉僵硬度与死亡率：来自NHANES和英国生物银行的证据
Yunzhao Hu 南方医科大学第八附属医院
1374-043 MOLECULAR DYNAMICS SIMULATIONS OF MIDKINE WITH AMP-ACTIVATED PROTEIN KINASE AND NLRX1: STRUCTURAL BASIS FOR ENHANCED MACROPHAGE MITOPHAGY AND CHOLESTEROL EFFLUX
1374-043
中期因子与AMP活化蛋白激酶及NLRX1的分子动力学模拟：增强巨噬细胞线粒体自噬和胆固醇外流的结构基础
Yuhan Yang 中南大学湘雅医院
1374-044 MACROPHAGE TRPV6 DELETION ATTENUATES ATHEROSCLEROSIS BY INHIBITING FOAM CELL FORMATION
1374-044
巨噬细胞TRPV6缺失通过抑制泡沫细胞形成减轻动脉粥样硬化
Feiyu Zhang 首都医科大学附属北京安贞医院
1375. Pulmonary Vascular Disease 04
2:00PM Poster Contributions
1375-060 PHARMACOKINETICS (PK) AND SAFETY OF MACITENTAN 75 MG: PHASE I DATA FROM CHINESE AND WHITE HEALTHY ADULTS
1375-060
马昔腾坦75 mg的药代动力学（PK）和安全性：来自中国和白人健康成年人的I期数据
李海燕 北京大学第三医院
1379. Cardiac Arrhythmias 04
2:00PM Poster Contributions
1379-102 ROLE OF DUAL THERAPIES WITH SACUBITRIL/VALSARTAN AND SGLT2 INHIBITORS IN REDUCED ARRHYTHMIC CLINICAL EVENTS AND HOSPITALISATIONS IN PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
1379-102
沙库巴曲/缬沙坦与SGLT2抑制剂双重治疗在减少植入式心律转复除颤器患者心律失常相关临床事件和住院中的作用
Yap-Hang Chan 香港大学玛丽医院
1380. Coronary, Peripheral and Structural Interventions 04
2:00PM Poster Contributions
1380-111 ANGIOGRAPHY-DERIVED FRACTIONAL FLOW RESERVE VERSUS INTRAVASCULAR ULTRASOUND TO GUIDE PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: A POST HOC ANALYSIS OF THE RANDOMIZED FLAVOUR II TRIAL
1380-111
血管造影衍生的FFR与IVUS在指导伴或不伴CKD患者经皮冠状动脉介入治疗中的比较：随机FLAVOUR II试验的事后分析
蒋峻 浙江大学医学院附属第二医院
1381. Valvular Diseases 04
2:00PM Poster Contributions
1381-129 ADIPOCYTE TRPM2 PROMOTES AORTIC DISSECTION BY ACCELERATING SMC PHENOTYPE SWITCHING
1381-129
脂肪细胞TRPM2通过加速平滑肌细胞表型转换促进主动脉夹层
Mi Wang 中南大学湘雅二医院
1382. Vascular Diseases 04
2:00PM Poster Contributions
1382-139 SESTRIN2 ALLEVIATES HYPERTENSION BY INHIBITING FERROPTOSIS VIA THE AMPK/NRF2/GPX4 SIGNALING PATHWAY
1382-139
SESTRIN2通过AMPK/NRF2/GPX4信号通路抑制铁死亡从而缓解高血压
吴皓宇 陕西省人民医院
1382-140 GLP-1 RECEPTOR AGONISTS REPROGRAM VASCULAR SMOOTH MUSCLE CELL METABOLISM TO ATTENUATE EXTRACELLULAR MATRIX REMODELING UNDER HYPERGLYCEMIC STRESS
1382-140
GLP-1受体激动剂重编程血管平滑肌细胞代谢以减轻高血糖应激下的细胞外基质重塑
刘仲伟 陕西省人民医院
1392. Complex Clinical Cases: Cardiac Arrhythmias 04
2:00PM Poster Contributions
1392-202 A RARE CASE OF ACQUIRED FREQUENT PVCS POST-HEART TRANSPLANT: TRANSMITTED FROM DONOR AND ELIMINATED BY ABLATION
1392-202
一例罕见的心脏移植术后获得性频发室性早搏：源自供体并通过消融术消除
Zihan Jiang 心血管疾病国家重点实验室
904. Highlighted Original Research: Vascular Diseases
2:00PM Oral Contributions
904-05 EMPAGLIFLOZIN AMELIORATES PATHOLOGICAL REMODELING IN THORACIC AORTIC ANEURYSM AND DISSECTION BY REDUCING THE UBIQUITINATION OF NLRP3 INFLAMMASOME
904-05
恩格列净通过减少NLRP3炎症小体的泛素化改善胸主动脉瘤和夹层的病理性重构
沈莉 中南大学湘雅二医院
1071. Endovascular Intervention for Peripheral Arterial Disease
3:30PM Moderated Poster Contributions
1071-05 MACHINE LEARNING FOR RISK STRATIFICATION AFTER ENDOVASCULAR REVASCULARIZATION IN PERIPHERAL ARTERY DISEASE
1071-05
机器学习用于外周动脉疾病血管内血运重建术后的风险分层
Huizi Yu 香港中文大学
1398. Cardiovascular Disease Prevention 05
3:30PM Poster Contributions
1398-053 PREDICTING CPAP-INDUCED BLOOD PRESSURE REDUCTION USING AMBULATORY BLOOD PRESSURE MONITORING IN OBSTRUCTIVE SLEEP APNEA
1398-053
使用动态血压监测预测持续气道正压通气在阻塞性睡眠呼吸暂停患者中引起的血压降低
谢江 首都医科大学附属北京安贞医院
1398-058 DOSE-RESPONSE ASSOCIATIONS OF CIRCULATING LEVELS OF VERY-LONG-CHAIN SATURATED FATTY ACIDS WITH ALL-CAUSE MORTALITY IN PATIENTS WITH CARDIOVASCULAR DISEASE
1398-058
循环中极长链饱和脂肪酸水平与心血管疾病患者全因死亡率的剂量-反应关系
Zewei Chen 中南大学
1400. Ischemic Heart Diseases 05
3:30PM Poster Contributions
1400-064 PROGNOSTIC IMPLICATIONS OF CORONARY MICROVASCULAR DYSFUNCTION IN ST-ELEVATION MYOCARDIAL INFARCTION BY OBESITY STATUS
1400-064
肥胖状态下冠状动脉微血管功能障碍在ST段抬高型心肌梗死（STEMI）中的预后意义
Qian Guo 首都医科大学附属北京安贞医院
1400-080 THE BURDEN OF TRADITIONAL RISK FACTORS MODIFIES THE ASSOCIATION BETWEEN LIPOPROTEIN(A) AND 10-YEAR CORONARY HEART DISEASE EVENT RISK
1400-080
传统危险因素负荷修饰脂蛋白(a)与10年冠心病事件风险之间的关联
Fanyong Xu 中国医学科学院阜外医院
1404. Coronary, Peripheral and Structural Interventions 05
3:30PM Poster Contributions
1404-098 SYSTEMATIC TWO-STENT VERSUS PROVISIONAL STENTING IN PATIENTS WITH TRUE CORONARY ARTERY BIFURCATION LESIONS: A POOLED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS OF RANDOMIZED TRIALS (DKCRUSH X TRIAL)
1404-098
系统性双支架策略与临时支架在真性冠状动脉分叉病变患者中的比较：一项基于随机试验的个体患者水平荟萃分析（DKCRUSH X 试验）
陈绍良 南京医科大学第一医院
1404-099 IVUS-GUIDED VERSUS ANGIOGRAPHY-GUIDED PCI IN DIABETIC PATIENTS WITH ACUTE CORONARY SYNDROMES: THE IVUS-ACS TRIAL
1404-099
IVUS引导与血管造影引导下PCI在急性冠脉综合征糖尿病患者中的比较：IVUS-ACS试验
陈绍良 南京医科大学第一医院
1405. Valvular Diseases 05
3:30PM Poster Contributions
1405-131 LONG-TERM OUTCOMES OF J-VALVE TRANSCATHETER AORTIC VALVE REPLACEMENT IN AORTIC STENOSIS OR AORTIC REGURGITATION: A LARGE-SCALE RETROSPECTIVE COHORT STUDY
1405-131
J-VALVE经导管主动脉瓣置换术治疗主动脉瓣狭窄或主动脉瓣反流的长期结局：一项大规模回顾性队列研究
Siyu He 四川大学华西医院
1406. Vascular Diseases 05
3:30PM Poster Contributions
1406-137 RESIDUAL CARDIOVASCULAR RISK ASSOCIATED WITH CUMULATIVE NON-HDL CHOLESTEROL EXPOSURE IN PATIENTS WITH PERIPHERAL ARTERY DISEASE
1406-137
累积非高密度脂蛋白胆固醇暴露与外周动脉疾病患者残余心血管风险的相关性
Yujia Zhang 香港中文大学
1418. Complex Clinical Cases: Heart Failure and Cardiomyopathies 05
3:30PM Poster Contributions
1418-269 MAVACAMTEN SIGNIFICANTLY REDUCES MIDVENTRICULAR OBSTRUCTION IN TWO PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: A CASE SERIES
1418-269
玛伐凯泰显著减轻两例肥厚型心肌病患者的心室中部梗阻：病例系列
Yutong Miao 上海交通大学医学院附属胸科医院
1419. Heart Failure and Cardiomyopathies 05
3:30PM Poster Contributions
1419-214 INTEGRATIVE TRANSCRIPTOMIC AND SINGLE-CELL ANALYSIS REVEALS MITOCHONDRIAL-RELATED GENE BIOMARKERS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
1419-214
整合转录组学与单细胞分析揭示HFpEF中的线粒体相关基因生物标志物
Fengchao Wu 陕西省人民医院
1419-236 A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM STUDY OF TRANS-FEMORAL PERCUTANEOUS INTRAMYOCARDIAL SEPTAL RADIOFREQUENCY ABLATION (TF-PIMSRA) IN PATIENTS WITH DRUG-REFRACTORY SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: THE PRIMO STUDY
1419-236 一项在药物难治性症状性梗阻性肥厚型心肌病患者中进行的经股动脉入路经皮心肌内室间隔射频消融术（TF-PIMSRA）的前瞻性、单中心、单臂研究：PRIMO研究
Yiyuan Huang 中南大学湘雅二医院
1419-239 INTERMUSCULAR ADIPOSE TISSUE DENSITY AS A SEX-SPECIFIC NOVEL PROGNOSTIC MARKER IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: A COMPREHENSIVE SINGLE-CENTER RETROSPECTIVE STUDY
1419-239
肌间脂肪组织密度作为HFpEF患者性别特异性的新型预后标志物：一项综合单中心回顾性研究
史凯蕾 复旦大学附属华东医院
3月29日
1084. Evolving Non-Statin Lipid Therapies
9:30AM Moderated Poster Contributions
1084-05 EFFICACY AND SAFETY OF LERODALCIBEP IN CHINESE PATIENTS WITH HYPERCHOLESTEROLEMIA:A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL
1084-05
Lerodalcibep在中国高胆固醇血症患者中的疗效与安全性：一项随机、双盲、安慰剂对照的3期试验
霍勇 北京大学第一医院
1084-07 LIPID-LOWERING EFFICACY AND SAFETY OF RECATICIMAB IN DYSLIPIDEMIA PATIENTS WITH OR WITHOUT TYPE 2 DIABETES MELLITUS: A POOLED PATIENT-LEVEL SUBGROUP ANALYSIS
1084-07
瑞卡西单抗在伴或不伴2型糖尿病的血脂异常患者中的降脂疗效与安全性：一项患者水平汇总的亚组分析
孙燕依 上海交通大学医学院附属瑞金医院
1421. Featured Fields 06
9:30AM Poster Contributions
1421-005 AEROBIC EXERCISE ATTENUATES PRESSURE-OVERLOAD CARDIOMYOPATHY VIA MICROBIOTA-BILE ACID-DEPENDENT RECRUITMENT OF GUT RORγT⁺ TREGS
1421-005
有氧运动通过微生物群-胆汁酸依赖性募集肠道RORγT⁺调节性T细胞减轻压力超负荷性心肌病
Leiling Liu 中南大学湘雅二医院
1421-006 AEROBIC EXERCISE IMPROVES PRESSURE OVERLOAD -INDUCED CARDIAC HYPERTROPHY BY REGULATING THE METABOLISM OF TREG CELLS
1421-006
有氧运动通过调节调节性T细胞代谢改善压力超负荷诱导的心脏肥大
Xiao Li 中南大学湘雅二医院
266. ANOCA, INOCA and MINOCA Boot Camp
10:45AM Scientific
266-08 Case Presentation: ANOCA - One Patient’s Journey From Diagnosis to Treatment
266-08
病例展示：ANOCA——一位患者从诊断到治疗的历程
Ming-Jui Hung 中国台湾
1096. Critical Care Cardiology and SchrÖdinger's Cat: Predicting Mortality in Shock
11:00AM Moderated Poster Contributions
1096-05 PROGNOSTIC VALUE OF THE LACTATE-ALBUMIN RATIO FOR 28-DAY MORTALITY IN CARDIOGENIC SHOCK
1096-05
乳酸-白蛋白比值对心源性休克患者28天死亡率的预后价值
Ruiqi Zhang 北京
1099. Advances in Detection and Prognosis of IHD
11:00AM Moderated Poster Contributions
1099-09 A MAGNETOCARDIOGRAPHY-DERIVED NOMOGRAM FOR PREDICTING CORONARY STENOSIS IN PATIENTS WITH NORMAL RESTING ECG
1099-09
一种心磁图衍生的列线图用于预测静息心电图正常患者的冠状动脉狭窄
Yufeng Jiang 苏州大学附属第四医院
1100. Deep-Learning Innovation for Prevention
11:00AM Moderated Poster Contributions
1100-11 A MULTIDIMENSIONAL MACHINE LEARNING MODEL INTEGRATING PCAT RADIOMICS AND CLINICAL RISK FOR PREDICTING INCIDENT CORONARY PLAQUE FORMATION: A LARGE CHINESE, MULTICENTER, COHORT STUDY
1100-11
一种整合心周脂肪组织（PCAT）影像组学与临床风险的多维机器学习模型用于预测新发冠状动脉斑块形成：一项中国大型多中心队列研究
Li Suyu 苏州大学附属第三医院
1102. Diagnostic Testing and Frameworks for Valvular Heart Disease: Evaluating Approaches for Prognostic Assessment
11:00AM Moderated Poster Contributions
1102-09 PROGNOSTIC VALUE OF EXTRA-AORTIC VALVE CARDIAC DAMAGE IN MODERATE VERSUS SEVERE AORTIC STENOSIS
1102-09
主动脉瓣外心脏损伤在中重度主动脉瓣狭窄患者中的预后价值
Jingjing HE 中山大学第一附属医院
1106. Integrating Genotype, Proteome and Phenotype Driving Cardiomyopathy
11:00AM Moderated Poster Contributions
1106-09 HYPOXIA RESPONSE AND VASCULAR SMOOTH MUSCLE CELL ACTIVATION DRIVE MICROENVIRONMENTAL REMODELING IN HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM SINGLE-CELL SEQUENCING
1106-09
缺氧反应与血管平滑肌细胞激活驱动肥厚型心肌病的微环境重塑：来自单细胞测序的见解
Fangyu Liu 复旦大学附属中山医院
1107. Molecular and Digital Biomarkers in Cardiovascular Disease and Heart Failure
11:00AM Moderated Poster Contributions
1107-09 LOW-DOSE SEMAGLUTIDE AMELIORATES PRESSURE OVERLOAD-INDUCED HEART FAILURE BY SUPPRESSING THE NAT10-AC4C-TGF-β1 AXIS
1107-09
低剂量司美格鲁肽通过抑制NAT10-AC4C-TGF-β1轴改善压力超负荷诱导的心力衰竭
Yiqing Hu 复旦大学附属中山医院
1107 INFERENCE OF SUB-CLINICAL LEFT VENTRICULAR GEOMETRIC REMODELING WITH DEEP LEARNING UNCOVERS INSIGHTS INTO METABOLIC CARDIOVASCULAR DISEASE
1107
利用深度学习推断亚临床左心室几何重构揭示对代谢性心血管疾病的见解
Yanpeng Ma 陕西省人民医院
1108. ACC Complex Clinical Cases: Cardiac Arrhythmias (Session 4)
11:00AM Moderated Poster Contributions
1108-11 DOUBLE-SNARE RETRIEVAL OF A DISLODGED ATRIAL LEADLESS PACEMAKER: A CASE REPORT
1108-11
双圈套器取回移位的无导线心房起搏器：病例报告
Sue-Ping Chang 国立台湾大学
1445. Featured Fields 07
11:00AM Poster Contributions
1445-018 NATIONAL TRENDS, PREDICTORS, AND CLINICAL OUTCOMES OF MECHANICAL CIRCULATORY SUPPORT IN CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION: A DECADE IN REVIEW (2012-2021)
1445-018
急性心肌梗死合并心源性休克患者中机械循环支持的全国趋势、预测因素及临床结局：十年回顾（2012-2021）
佟倩 吉林大学第一医院
1446. Cardiovascular Disease Prevention 07
11:00AM Poster Contributions
1446-055 FRAILTY, GENETIC RISK, AND INFLAMMATORY MEDIATION IN CORONARY ARTERY DISEASE: EVIDENCE FROM A LARGE POPULATION-BASED COHORT
1446-055 冠状动脉疾病中衰弱、遗传风险和炎症介导：来自一项大型基于人群的队列研究的证据
Yanwen Fang 中国医学科学院阜外医院
1452. Coronary, Peripheral and Structural Interventions 07
11:00AM Poster Contributions
1452-096 LESION LENGTH DEPENDENT EFFECTS OF QUANTITATIVE FLOW RATIO GUIDED PERCUTANEOUS CORONARY INTERVENTION
1452-096
定量血流比指导经皮冠状动脉介入治疗的病灶长度依赖性效应
Xunxun Feng 首都医科大学
1467. Heart Failure and Cardiomyopathies 07
11:00AM Poster Contributions
1467-209 DEVELOPMENT AND VALIDATION OF AN INTERPRETABLE PREDICTION MODEL FOR SUCCESSFUL WEANING FROM VA-ECMO IN PEDIATRIC PATIENTS: A MULTICENTER RETROSPECTIVE COHORT STUDY IN CHINA
1467-209
儿童静脉-动脉体外膜肺氧合（VA-ECMO）成功撤机可解释预测模型的开发与验证：一项中国多中心回顾性队列研究
张然 中国人民解放军东部战区总医院
276. Featured Clinical Research III
12:15PM Late-Breaking Clinical Trials
276-09 Coronary CT Derived Fractional Flow Reserve-guided Management Of Patients With Stable CAD: 3-year Outcomes From A Multicentre, Pragmatic, Open-label, Randomised Controlled Trial In China
276-09
基于冠脉CT衍生的FFR指导的稳定性冠心病（CAD）患者管理：一项中国多中心、实用性、开放标签、随机对照试验的3年结果
唐春香 中国人民解放军东部战区总医院
276-11 Role Of Screening With Coronary Computed Tomography Angiography In Lipid Management In An Asymptomatic Chinese Population: A Community-based, Parallel-group, Open-label, Randomized Clinical Trial (RESPECT2)
276-11
冠状动脉CT血管造影筛查在无症状中国人群血脂管理中的作用：一项基于社区、平行组、开放标签的随机临床试验（RESPECT2）
郭翔 中国人民解放军东部战区总医院
1115. Novel Therapeutics in MI and ACS Management
12:15PM Moderated Poster Contributions
1115-03 EARLY VERICIGUAT ADJUNCTIVE THERAPY IMPROVES LEFT VENTRICULAR REMODELING IN POST-AMI PATIENTS WITH REDUCED EJECTION FRACTION
1115-03
早期维利西呱辅助治疗改善射血分数降低的急性心肌梗死后患者的左心室重构
Daoyuan Si 吉林大学中日联谊医院
1117. A Po' Boy and Hot Sauce: Pulmonary Hypertension and Heart Failure
12:15PM Moderated Poster Contributions
1117-05 COMPREHENSIVE BIOINFORMATIC ANALYSIS IDENTIFIES M6A METHYLATION AS A KEY MEDIATOR LINKING IMMUNITY TO IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
1117-05
综合生物信息学分析确定M6A甲基化为连接免疫与特发性肺动脉高压的关键介质
刘娜 中南大学湘雅二医院
1468. Featured Fields 08
12:15PM Poster Contributions
1468-007 ACCELEROMETER-MEASURED PHYSICAL ACTIVITY PATTERNS AND RISK OF MACE AND MORTALITY IN HYPERTENSIVE ADULTS
1468-007
加速度计测量的体力活动模式与高血压成人主要心血管不良事件及死亡风险
Bing Hu 南方医科大学第八附属医院
1471. Ischemic Heart Diseases 08
12:15PM Poster Contributions
1471-064 INHIBITION OF LACTATE DEHYDROGENASE A REDIRECTS GLUCOSE METABOLISM TO THE PENTOSE PHOSPHATE PATHWAY TO PROTECT CARDIOMYOCYTES IN MYOCARDIAL ISCHEMIA-REPERFUSION INJURY
1471-064
抑制乳酸脱氢酶A将葡萄糖代谢重定向至磷酸戊糖途径，从而在心肌缺血再灌注损伤中保护心肌细胞
Ke Zhu 上海
1471-068 IMMUNE CHECKPOINT PD-1 SHAPES THE IMMUNE RESPONSE AND FUNCTIONAL RECOVERY AFTER MYOCARDIAL INFARCTION
1471-068
免疫检查点PD-1塑造心肌梗死后免疫反应和功能恢复
Xiqiang Wang 陕西省人民医院
1471-077 MYOCARDIAL FUNCTION AMELIORATING AND UNDERLING MECHANISMS FOR SDF-1α LOADED JANUS CARDIAC PATCH IN RATS AFTER MYOCARDIAL INFARCTION
1471-077
负载SDF-1α的Janus心脏贴片在改善大鼠心肌梗死后心肌功能及其潜在机制
张静 陕西省人民医院
1490. Heart Failure and Cardiomyopathies 08
12:30PM Poster Contributions
1490-240 SEX DIFFERENCES IN CLINICAL CHARACTERISTICS, GENETIC PROFILES AND OUTCOMES OF LEFT VENTRICULAR HYPERTRABECULATION
1490-240
左心室过度小梁化的临床特征、遗传谱型及预后的性别差异
Kun-Qi Yang 中国医学科学院阜外医院
908. Highlighted Original Research: Ischemic Heart Disease
12:30PM Oral Contributions
908-07 PAD4-KNOCKDOWN M2-TYPE CAR-MS ENGULF NEUTROPHIL EXTRACELLULAR TRAPS AND ALLEVIATE POST-MYOCARDIAL INFARCTION FIBROSIS
908-07
PAD4敲低的M2型CAR-M细胞吞噬中性粒细胞胞外诱捕网并缓解心肌梗死后纤维化
Siyu He 四川大学华西医院
294. Cardiovascular Risk Reimagined: The Future of Stratification in Cardiovascular Care
1:45PM Scientific
294-09 Future-Proofing the Young: Personalized Prevention for Early Cardiovascular Risk
294-09
为年轻人未雨绸缪：早期心血管风险的个性化预防
Dong Zhao 北京
1129. Innovations and Challenges in CV Risk of Immunotherapy
2:00PM Moderated Poster Contributions
1129-09 GUT MICROBIOTA-DERIVED TRIMETHYLAMINE N-OXIDE IS ESSENTIAL IN IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS AND MAY SERVE AS A POTENTIAL PHARMACOLOGICAL TARGET
1129-09
肠道菌群衍生的氧化三甲胺在免疫检查点抑制剂相关性心肌炎中至关重要，可能作为潜在的药理学靶点
杨新宇 吉林大学第一医院
1133. Social Factors Driving Cardiovascular Outcomes
2:00PM Moderated Poster Contributions
1133-11 SHIFT WORK, SLEEP DURATION, AND MYOCARDIAL DYNAMICS: A CARDIAC MAGNETIC RESONANCE STUDY OF UK BIOBANK
1133-11
轮班工作、睡眠时长与心肌动力学：一项基于英国生物银行的心脏磁共振研究
Zhen'ge Chang 中国医学科学院阜外医院
1135. Drug Coated Balloon Technologies
2:00PM Moderated Poster Contributions
1135-11 ONE-YEAR REAL-WORLD OUTCOMES OF THE BIOFREEDOM POLYMER-FREE DRUG-COATED STENT SYSTEM IN CHINESE PATIENTS AT HIGH BLEEDING RISK: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY
1135-11
高出血风险中国患者使用BioFreedom无聚合物药物涂层支架系统的一年真实世界结果：一项前瞻性、多中心、观察性研究
马根山 东南大学附属中大医院
1493. Cardiovascular Disease Prevention
2:00PM Poster Contributions
1493-032 UNSUPERVISED IDENTIFICATION OF SLEEP CARDIOMETABOLIC SUBTYPES AND THEIR ASSOCIATION WITH LONG TERM CARDIOVASCULAR EVENTS IN A COMMUNITY BASED COHORT
1493-032
社区队列中睡眠心代谢亚型的无监督识别及其与长期心血管事件的关联
Zhihua Huang 中国医学科学院阜外医院
1493-049 INTEGRATING LIVER FIBROSIS INTO THE CKM SYNDROME: EVIDENCE FROM A LARGE-SCALE POPULATION COHORT
1493-049
将肝纤维化纳入心肾代谢综合征：来自一项大规模人群队列的证据
Yanwen Fang 中国医学科学院阜外医院
1494. Pulmonary Vascular Disease 09
2:00PM Poster Contributions
1494-062 CORRELATION BETWEEN INFLAMMATORY MARKERS AND PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE
1494-062
炎症标志物与先天性心脏病相关肺动脉高压的相关性
戴海龙 昆明医科大学附属延安医院
1497. Multimodal Imaging 09
2:00PM Poster Contributions
1497-089 FOUR-DIMENSIONAL ECHOCARDIOGRAPHY REVEALS THE IMPACT OF ACE GENE POLYMORPHISM ON EARLY DIASTOLIC FUNCTION IN HYPERTENSION
1497-089
四维超声心动图揭示ACE基因多态性对高血压患者早期舒张功能的影响
Xinyu Cheng 苏州大学附属第四医院
1514. Heart Failure and Cardiomyopathies 09
2:00PM Poster Contributions
1514-211 DIFFERENTIAL EXPRESSION PROFILING OF E3 UBIQUITIN LIGASE GENES IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION VIA RNA SEQUENCING AND E3ATLAS-BASED ANALYSIS
1514-211
通过RNA测序和E3ATLAS分析对HFpEF患者外周血单个核细胞中E3泛素连接酶基因的差异表达谱分析
阳辉 中南大学湘雅二医院
1514-215 IMMUNE CHECKPOINT PD-1 ATTENUATES HEART FAILURE BY RESTRAINING CROSSTALK BETWEEN CD8⁺ T CELLS AND CCR2⁺ MACROPHAGES
1514-215
免疫检查点PD-1通过抑制CD8⁺ T细胞与CCR2⁺巨噬细胞之间的交互作用减轻心力衰竭
Jing Liu 陕西省人民医院
1514-216 TRAF2-DEPENDENT MITOPHAGY RESTORES MITOCHONDRIAL FUNCTION AND PREVENTS RECURRENCE IN HEART FAILURE WITH IMPROVED EJECTION FRACTION
1514-216
TRAF2依赖性线粒体自噬恢复线粒体功能并预防射血分数改善的心力衰竭的复发
Yanpeng Ma 陕西省人民医院
1514-217 PIEZO1 BLOCKADE ATTENUATES PRESSURE-OVERLOAD CARDIAC REMODELING UNDER STANDARDIZED ANESTHESIA CONDITIONS
1514-217
PIEZO1阻断在标准化麻醉条件下减轻压力超负荷所致的心脏重构
张玉明 陕西省人民医院
1514-218 ANESTHESIA-DEPENDENT MECHANOTRANSDUCTION THROUGH YAP/TAZ SIGNALING DRIVES PRESSURE-OVERLOAD FIBROSIS
1514-218
麻醉依赖性通过YAP/TAZ信号通路的机械转导驱动压力超负荷纤维化
张玉明 陕西省人民医院
1154. Silencers, Stabilizers and Therapeutic Progress in Transthyretin Amyloidosis
3:30PM Moderated Poster Contributions
1154-05 RNA INTERFERENCE THERAPEUTICS REDUCE CARDIAC ARRHYTHMIAS AND ARRHYTHMIC HOSPITALISATIONS IN NON-TAFAMIDIS USERS WITH TRANSTHYRETIN AMYLOIDOSIS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
1154-05
RNA干扰疗法减少未使用Tafamidis者中转甲状腺素淀粉样变性患者的心律失常及心律失常相关住院：一项随机对照试验的荟萃分析
Yap-Hang Chan 香港大学玛丽医院
1155. Beyond the Scar: Mechanisms, Modifiers and Markers of Myocardial Fibrosis
3:30PM Moderated Poster Contributions
1155-09 ASSESSMENT OF MYOCARDIAL STRAIN FOR PREDICTING CARDIAC DYSFUNCTION AND MYOCARDIAL FIBROSIS IN DUCHENNE MUSCULAR DYSTROPHY
1155-09
评估心肌应变以预测杜氏肌营养不良症患者的心脏功能障碍和心肌纤维化
Mei HU 四川大学华西第二医院
1155-11 MULTI-OMIC INSIGHTS INTO THE ASSOCIATIONS BETWEEN MODIFIABLE FACTORS AND MYOCARDIAL FIBROSIS
1155-11
多组学视角下可调控因素与心肌纤维化之间的关联
Teng Hu 四川大学华西医院
1516. Featured Fields 10
3:30PM Poster Contributions
1516-028 KNOWLEDGE, ATTITUDE, AND PRACTICE BEHAVIORAL REINFORCEMENT BY SMART GUIDANCE ENGINE FOR VENOUS THROMBOEMBOLISM: A RANDOMIZED CONTROLLED TRIAL
1516-028
通过智能指导引擎对静脉血栓栓塞症进行知识、态度和实践行为强化：一项随机对照试验
Binbin Liu 中国人民解放军总医院
1517. Cardiovascular Disease Prevention 10
3:30PM Poster Contributions
1517-049 DIETARY INDEX FOR GUT MICROBIOTA, ENTEROLACTONE AND CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME: SHARED GLUCOSE PATHWAYS AND MULTI-TARGET MECHANISMS
1517-049
肠道微生物群、肠内酯与心血管-肾脏-代谢综合征的膳食指数：共享的葡萄糖通路与多靶点机制
Weixing Wen 南方医科大学第八附属医院
3月30日
321. Featured Clinical Research V
8:30AM Late-Breaking Clinical Trials
321-09 Efficacy And Safety Of BHB/HRS-1893 In Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From A 12-week Phase 2 Study
321-09
BHB/HRS-1893在症状性梗阻性肥厚型心肌病中的疗效与安全性：一项12周2期研究结果
Limei Wang 中国医学科学院阜外医院
1540. Featured Fields 11
9:30AM Poster Contributions
1540-013 PRE-EXISTING HEART FAILURE AND SEPSIS OUTCOMES: A MULTICENTER COMPETING-RISKS AND TIME-VARYING EFFECT ANALYSIS
1540-013
既往心力衰竭与脓毒症结局：一项多中心竞争风险与时变效应分析
Jing Liu 陕西省人民医院
1540-028 CARDIAC SUBSTRUCTURE DOSE PARAMETERS AS PREDICTORS OF CARDIAC EVENTS IN ESOPHAGEAL CANCER PATIENTS FOLLOWING DEFINITIVE CHEMORADIOTHERAPY
1540-028
心脏亚结构剂量参数作为食管癌患者接受根治性放化疗后心脏事件的预测因子
Yue Huang 云阳县人民医院
1541. Cardiovascular Disease Prevention 11
9:30AM Poster Contributions
1541-037 TIMP1 AS A PROMISING PLASMA BIOMARKER AND THERAPEUTIC TARGET FOR IDENTIFYING AT-RISK SEVERE STEATOTIC LIVER DISEASE
1541-037
TIMP1作为识别高风险重度脂肪性肝病的有前景的血浆生物标志物和治疗靶点
Ziang Li 中国医学科学院阜外医院
1542. Pulmonary Vascular Disease 11
9:30AM Poster Contributions
1542-059 PREDICTIVE VALUE OF MULTIPLE INFLAMMATORY BIOMARKERS FOR FUNCTIONAL LIMITATION AT 3 MONTHS POST-ACUTE PULMONARY EMBOLISM
1542-059
多种炎症生物标志物对急性肺栓塞后3个月功能受限的预测价值
Beilan Yang 中国医学科学院阜外医院
1562. Heart Failure and Cardiomyopathies 11
9:30AM Poster Contributions
1562-222 KALLISTATIN AMELIORATES DIABETIC CARDIOMYOPATHY BY REDUCING OXIDATIVE STRESS THROUGH THE MIR-34A-SIRT1-FOXO1 PATHWAY
1562-222
Kallistatin通过miR-34A-SIRT1-FOXO1通路减轻氧化应激从而改善糖尿病心肌病
Yuli Huang 南方医科大学第八附属医院
911. Highlighted Original Research: Cardiac Arrhythmias
9:30AM Oral Contributions
911-12 INCIDENCE AND PROGNOSIS OF HEART FAILURE IN LEFT BUNDLE BRANCH BLOCK
911-12
左束支传导阻滞患者心力衰竭的发病率与预后
Sijing Cheng 中国医学科学院阜外医院
112. Late-Breaking Clinical Trials VII
10:45AM Late-Breaking Clinical Trials
112-13 Ivus Or Angiography Guidance For Pci In Complex Coronary Bifurcation Lesions
112-13
IVUS或血管造影引导下PCI治疗复杂冠状动脉分叉病变
陈绍良 南京医科大学第一医院
1179. Improved Detection of ACS and CAD: Tests & Biomarkers
11:00AM Moderated Poster Contributions
1179-11 MACHINE LEARNING-BASED IN-HOSPITAL OUTCOME PREDICTING VARIABLES FOR ACUTE CORONARY SYNDROME: ANALYSIS FROM THE CCC-ACS PROJECT IN CHINA
1179-11
基于机器学习的急性冠脉综合征院内结局预测变量：来自中国CCC-ACS项目分析
Jiarui Fa 东南大学附属中大医院
1180. Linking Lipid Metrics to CVD Risks
11:00AM Moderated Poster Contributions
1180-05 THE MONOCYTE TO HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO IS ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY AMONG INDIVIDUALS WITH HYPERTENSION
1180-05
单核细胞与高密度脂蛋白胆固醇比值与高血压患者全因及心血管死亡率相关
Rongting Zhang 同济大学附属东方医院
1180-11 IMPACT OF LDL-C AND APOLIPOPROTEIN B LEVEL DISCORDANCE AND ASSOCIATED LIPOPROTEIN PARTICLE ALTERATIONS ON CARDIOVASCULAR OUTCOMES IN A LARGE PRIMARY PREVENTION POPULATION
1180-11
低密度脂蛋白胆固醇（LDL-C）与载脂蛋白B水平不一致及其相关脂蛋白颗粒改变对大规模一级预防人群心血管结局的影响
Yuan Du 中国医学科学院阜外医院
1572. Valvular Diseases 12
11:00AM Poster Contributions
1572-132 REAL-WORLD EFFECTIVENESS AND SAFETY OF DIRECT ORAL ANTICOAGULANTS VERSUS WARFARIN IN ASIAN PATIENTS WITH ATRIAL FIBRILLATION AND MITRAL STENOSIS:A PREVALENT NEW-USER DESIGN STUDY
1572-132
直接口服抗凝药与华法林在合并二尖瓣狭窄的亚洲房颤患者中的真实世界疗效与安全性：一项普遍新用药者设计研究
Yu Yang 香港
1573-136 LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AND RISK OF ABDOMINAL AORTIC ANEURYSM RUPTURE: INSIGHTS FROM A MULTICENTER CASE-CONTROL STUDY
1573-136
低密度脂蛋白胆固醇水平与腹主动脉瘤破裂风险：来自多中心病例对照研究的见解
杨静博 天津医科大学总医院
1578. Complex Clinical Cases: Ischemic Heart Diseases 12
11:00AM Poster Contributions
1578-155 UNRAVELLING HEPARIN-INDUCED THROMBOCYTOPENIA UNDER MECHANICAL CIRCULATORY SUPPORT IN ACUTE MYOCARDIAL INFARCTION AND ARRHYTHMIC STORM
1578-155
解析急性心肌梗死和心律失常风暴患者接受机械循环支持时肝素诱导的血小板减少症
Qi WANG 中国医学科学院阜外医院
1581. Complex Clinical Cases: Structural Interventions 12
11:00AM Poster Contributions
1581-179 TIME IS A VALVE: A STUCK LEAFLET AFTER IMPLANTATION OF A TAURUSELITE VALVE WITH SPONTANEOUS RESOLUTION IN A PATIENT WITH SEVERE MIXED AORTIC VALVE DISEASE
1581-179
时间就是瓣膜：一例重度混合性主动脉瓣疾病患者植入TaurusElite瓣膜后瓣叶卡顿并自发缓解
牛文豪 海军军医大学第二附属医院
1586. Heart Failure and Cardiomyopathies 12
11:00AM Poster Contributions
1586-236 THE VALUE OF CARDIOPULMONARY EXERCISE TESTING IN EVALUATING SUBCLINICAL CARDIAC DYSFUNCTION IN UNEXPLAINED DYSPNEA OVERWEIGHT PATIENTS
1586-236
心肺运动试验在评估不明原因呼吸困难超重患者亚临床心脏功能障碍中的价值
褚松筠 北京大学第一医院
1586-240 LEVERAGING THE PROGNOSTIC NUTRITIONAL INDEX AS A NOVEL TOOL FOR HEART FAILURE RISK STRATIFICATION IN HYPERTENSION
1586-240
利用预后营养指数作为高血压患者心力衰竭风险分层的新工具
Jiankai Zhong 南方医科大学第八附属医院
1192. Impact of Digital Health and AI in Outpatient and Preventative Cardiology
12:30PM Moderated Poster Contributions
1192-07 DETECTING VALVULAR HEART DISEASE ASSOCIATED MURMUR WITH SMARTPHONE MICROPHONE
1192-07
使用智能手机麦克风检测心脏瓣膜病相关杂音
Chun Ka Wong 香港大学
1194. Hearts on Fire: Insights from Advanced Imaging
12:30PM Moderated Poster Contributions
1194-07 A PLATELET-BASED MITOCHONDRIAL DELIVERY SYSTEM ALLEVIATE MYOCARDIAL ISCHEMIA-REPERFUSION INJURY VIA TARGETING MACROPHAGES
1194-07
一种基于血小板的线粒体递送系统通过靶向巨噬细胞缓解心肌缺血再灌注损伤
陈妍梅 南方医科大学南方医院
1196. Adiposity-Driven Cardiometabolic Risk
12:30PM Moderated Poster Contributions
1196-09 PROGNOSTIC IMPLICATIONS OF OBSTRUCTIVE SLEEP APNEA IN ACUTE CORONARY SYNDROME BY RESIDUAL CHOLESTEROL INFLAMMATION INDEX
1196-09
基于残余胆固醇炎症指数探究阻塞性睡眠呼吸暂停在急性冠脉综合征中的预后意义
Mingrui Zhang 首都医科大学附属北京安贞医院
1199. Evolving Perspectives in Renal Artery Stenosis, CKD and Hypertension
12:30PM Moderated Poster Contributions
1199-09 ATHEROGENIC AND SYSTEMIC IMMUNE-INFLAMMATION INDICES FOR EARLY DETECTION OF CORONARY ARTERY DISEASE IN CHRONIC KIDNEY DISEASE
1199-09
用于慢性肾病患者冠状动脉疾病早期检测的致动脉粥样硬化指数和全身免疫炎症指数
Neha Yalamanchi 中南大学湘雅医院
1202. Bench to Bedside Innovations in Heart Failure Care
12:30PM Moderated Poster Contributions
1202-03 ENGINEERED MESENCHYMAL STROMAL CELL-DERIVED EXOSOMES IMPROVE DUCHENNE MUSCULAR DYSTROPHY ASSOCIATED CARDIOMYOPATHY
1202-03
工程化间充质基质细胞来源的外泌体改善杜氏肌营养不良相关心肌病
Huayan Xu 成都出生缺陷与妇儿相关疾病教育部重点实验室
1588. Cardiovascular Disease Prevention 13
12:30PM Poster Contributions
1588-039 FRAILTY TRAJECTORY PATTERNS AND RISK OF CARDIOVASCULAR DISEASE: EVIDENCE FROM TWO PROSPECTIVE COHORTS
1588-039
虚弱轨迹模式与心血管疾病风险：来自两项前瞻性队列的证据
Menglu Liu 中国医学科学院阜外医院
1588-044 FIBROSIS-4 INDEX-DEFINED ADVANCED LIVER FIBROSIS PREDICTS CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME
1588-044
由FIBROSIS-4指数定义的晚期肝纤维化预测急性冠脉综合征患者的心血管事件
xiangyun Kong 首都医科大学附属北京安贞医院
1588-052 ENHANCING LONG-TERM CARDIOVASCULAR RISK STRATIFICATION: INTEGRATING BIOMARKERS INTO THE VERY HIGH-RISK ASCVD DEFINITION IN ASIAN PATIENTS
1588-052
增强长期心血管风险分层：将生物标志物整合入亚洲患者极高危ASCVD定义
王浩宇 中国医学科学院阜外医院
1588-055 HEART RATE VARIABILITY AND AUTOMATIC POSITIVE AIRWAY PRESSURE VENTILATION IN PATIENTS WITH CARDIOVASCULAR DISEASE AND SLEEP APNEA
1588-055
心率变异性与自动气道正压通气在心血管疾病和睡眠呼吸暂停患者中的应用
Xiaozhao Lu 广东省人民医院
1590. Ischemic Heart Diseases 13
12:30PM Poster Contributions
1590-063 TEMPORAL SHIFTS IN ISCHEMIC AND BLEEDING RISK DOMINANCE:THE ARC-HBR TRADE-OFF MODEL
1590-063
缺血与出血风险主导地位的时间变化：ARC-HBR权衡模型
王浩宇 中国医学科学院阜外医院
1590-068 EFFECT OF PROLONGED ANTICOAGULATION ON MYOCARDIAL INJURY AFTER PRIMARY PCI FOR STEMI: RIGHT CMR SUBSTUDY
1590-068
延长抗凝治疗对STEMI患者接受直接PCI后心肌损伤的影响：RIGHT CMR亚组研究
Yingying Guo 中国医学科学院阜外医院
1590-079 ASSOCIATION BETWEEN METABOLIC SCORE FOR INSULIN RESISTANCE AND ADVERSE CARDIAC OUTCOMES IN ACUTE CORONARY SYNDROME PATIENTS WITHOUT STANDARD MODIFIABLE CARDIOVASCULAR RISK FACTORS
1590-079
胰岛素抵抗代谢评分在无标准可改变心血管危险因素的急性冠脉综合征患者中与不良心脏结局的关联
Xiaoming Zhang 首都医科大学附属北京安贞医院
1594. Coronary, Peripheral and Structural Interventions 13
12:30PM Poster Contributions
1594-112 WHO BENEFITS FROM ANGIOGRAPHY-DERIVED FFR-GUIDED REVASCULARIZATION? DEFINING THE BENEFICIAL POPULATION AND ITS KEY FEATURES
1594-112
谁能从血管造影衍生的FFR指导的血运重建中获益？确定获益人群及其关键特征
王浩宇 中国医学科学院阜外医院
1606. Complex Clinical Cases: Cardiac Arrhythmias 13
12:30PM Poster Contributions
1606-200 GLOBAL RESET AND RESYNCHRONIZE-COMBINED BACHMANN BUNDLE AND HIS BUNDLE PACING
1606-200
整体复位与再同步—联合Bachmann束和希氏束起搏
褚松筠 北京大学第一医院
366. Investigative Horizons III
1:45PM Late-Breaking Clinical Trials
366-08 Artificial Intelligence Model For Evaluating Surgical Techniques Of Cardiac Surgeons
366-08
用于评估心脏外科医生手术技术的人工智能模型
袁昕 中国医学科学院阜外医院
信源：ACC.26官网
编辑&审校：siqili
排版：siqili
医脉通是专业的在线医生平台，“感知世界医学脉搏，助力中国临床决策”是平台的使命。医脉通旗下拥有「临床指南」「用药参考」「医学文献王」「医知源」「e研通」「e脉播」等系列产品，全面满足医学工作者临床决策、获取新知及提升科研效率等方面的需求。
本平台旨在为医疗卫生专业人士传递更多医学信息。本平台发布的内容，不能以任何方式取代专业的医疗指导，也不应被视为诊疗建议。如该等信息被用于了解医学信息以外的目的，本平台不承担相关责任。本平台对发布的内容，并不代表同意其描述和观点。若涉及版权问题，烦请权利人与我们联系，我们将尽快处理。
